Skip to main content
. Author manuscript; available in PMC: 2012 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Aug 6;256(2):122–135. doi: 10.1016/j.taap.2011.07.019

Fig. 3.

Fig. 3

Hepatic mRNAs of Nrf2-target antioxidative genes in TCDD-treated Nrf2-null mice. Mean ± SE. N=4–5. * p ≤ 0.05 versus corresponding vehicle-treated mice; † p ≤ 0.05 versus corresponding wild-type mice.